Form D · Pharmaceuticals

Araim Pharmaceuticals, Inc.

Tarrytown, NY · CIK 0001625178

Offering snapshot reported Nov 15, 2017 · SEC filing

Reported sold: $4.1M
Investors reported: 5
Minimum accepted: $0
First sale: Aug 29, 2017

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$4,002,429 → $4,102,429
Reported investors4 → 5

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 15, 2017	Amendment	$4,102,429	$100,000vs Sep 13, 2017	5	SEC filing
Sep 13, 2017	Initial	$4,002,429	No comparison	4	SEC filing
Nov 17, 2014	Initial	$4,000,000	No comparison	5	SEC filing

Offering details

Securities: Debt
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-294624

Source: Form D, filed Nov 15, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Gerald Bernstein	Director
Ferry Breedveld	Director
Michael Brines	Director, Executive
Anthony Cerami	Director
Ann Dunne	Director, Executive
Scott Grundy	Director
Sarah Haley	Executive
Rita Kirk	Executive
John Macomber	Director
Sidney Strickland	Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

580 White Plains Road, Suite 210
Tarrytown, NY, 10591